• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bone Biologics Corp - Common Stock (NQ:BBLG)

    1.134 +0.054 (+5.01%)
    Streaming Delayed Price Updated: 2:18 PM EDT, Jul 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,542
    Open 1.110
    Bid (Size) 1.090 (1,700)
    Ask (Size) 1.140 (500)
    Prev. Close 1.080
    Today's Range 1.090 - 1.140
    52wk Range 1.050 - 4.130
    Shares Outstanding 1,795,260
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities
    Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2 2027 
    From BONE BIOLOGICS CORPORATION
    Via GlobeNewswire
    News headline image
    Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    $3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds upon the exercise in full of warrants in cash 
    From BONE BIOLOGICS CORPORATION
    Via GlobeNewswire

    Performance

    YTD
    -26.4%
    -26.4%
    1 Month
    -17.8%
    -17.8%
    3 Month
    -16.0%
    -16.0%
    6 Month
    -35.6%
    -35.6%
    1 Year
    -62.9%
    -62.9%

    More News

    Read More
    News headline image
    Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1
    From BONE BIOLOGICS CORPORATION
    Via GlobeNewswire
    News headline image
    Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook
    From BONE BIOLOGICS CORPORATION
    Via GlobeNewswire
    News headline image
    Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
    From BONE BIOLOGICS CORPORATION
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Discover the most active stocks in Thursday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    News headline image
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Thursday? ↗
    Via Chartmill
    News headline image
    Top movers in Thursday's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
    From Bone Biologics Corporation
    Via Business Wire
    News headline image
    Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference
    From Bone Biologics Corporation
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Bone Biologics Announces Closing of $5.0 Million Public Offering
    From Bone Biologics Corporation
    Via Business Wire
    News headline image
    Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Valuation, Nasdaq Compliance Etc. – More Stocks Inside
    Via AB Newswire
    Topics Regulatory Compliance
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Why Is Bone Biologics Stock Surging On Friday? ↗
    Via Benzinga
    Topics Intellectual Property
    News headline image
    Bone Biologics Announces Pricing of $5.0 Million Public Offering
    From Bone Biologics Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Bone Biologics Corp - Common Stock publicly traded?
    Yes, Bone Biologics Corp - Common Stock is publicly traded.
    What exchange does Bone Biologics Corp - Common Stock trade on?
    Bone Biologics Corp - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Bone Biologics Corp - Common Stock?
    The ticker symbol for Bone Biologics Corp - Common Stock is BBLG on the Nasdaq Stock Market
    What is the current price of Bone Biologics Corp - Common Stock?
    The current price of Bone Biologics Corp - Common Stock is 1.134
    When was Bone Biologics Corp - Common Stock last traded?
    The last trade of Bone Biologics Corp - Common Stock was at 07/24/26 02:18 PM ET
    What is the market capitalization of Bone Biologics Corp - Common Stock?
    The market capitalization of Bone Biologics Corp - Common Stock is 2.04M
    How many shares of Bone Biologics Corp - Common Stock are outstanding?
    Bone Biologics Corp - Common Stock has 2M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.